This policy research examines regulatory frameworks for AI-based medical devices and continuous monitoring systems. As AI tools become increasingly common in healthcare, clear regulatory pathways are essential for ensuring safety and efficacy while enabling innovation.
Current regulatory frameworks were designed for traditional medical devices and pharmaceuticals. AI systems present unique regulatory challenges including continuously evolving algorithms, adaptive learning capabilities, and the need for ongoing performance monitoring.
We propose a tiered regulatory approach that varies requirements based on risk level and system autonomy. Lower-risk decision support systems require less stringent approval than higher-risk autonomous diagnostic systems.
Key elements include: pre-market validation, post-market surveillance, performance monitoring, and transparent communication with users about AI involvement in clinical decisions.
Effective regulation requires coordination across regulatory agencies. We recommend harmonized international standards to avoid regulatory fragmentation that could slow innovation and patient access to beneficial technologies.
Smart regulatory frameworks can enable beneficial AI in healthcare while maintaining patient safety through appropriate oversight.